» Articles » PMID: 33996914

Approaches for the Design and Optimization of Interfering Peptides Against Protein-Protein Interactions

Abstract

Large contact surfaces of protein-protein interactions (PPIs) remain to be an ongoing issue in the discovery and design of small molecule modulators. Peptides are intrinsically capable of exploring larger surfaces, stable, and bioavailable, and therefore bear a high therapeutic value in the treatment of various diseases, including cancer, infectious diseases, and neurodegenerative diseases. Given these promising properties, a long way has been covered in the field of targeting PPIs peptide design strategies. tools have recently become an inevitable approach for the design and optimization of these interfering peptides. Various algorithms have been developed to scrutinize the PPI interfaces. Moreover, different databases and software tools have been created to predict the peptide structures and their interactions with target protein complexes. High-throughput screening of large peptide libraries against PPIs; "hotspot" identification; structure-based and off-structure approaches of peptide design; 3D peptide modeling; peptide optimization strategies like cyclization; and peptide binding energy evaluation are among the capabilities of tools. In the present study, the most recent advances in the field of approaches for the design of interfering peptides against PPIs will be reviewed. The future perspective of the field and its advantages and limitations will also be pinpointed.

Citing Articles

Innovative CDR grafting and computational methods for PD-1 specific nanobody design.

Devasani J, Guntuku G, Panatula N, Muthyala M, Palla M, Siahaan T Front Bioinform. 2025; 4:1488331.

PMID: 39897125 PMC: 11782559. DOI: 10.3389/fbinf.2024.1488331.


In-silico and in-vitro study of novel antimicrobial peptide AM1 from Aegle marmelos against drug-resistant Staphylococcus aureus.

Awdhesh Kumar Mishra R, Kodiveri Muthukaliannan G Sci Rep. 2024; 14(1):25822.

PMID: 39468175 PMC: 11519352. DOI: 10.1038/s41598-024-76553-0.


Characterization and preparation of food-derived peptides on improving osteoporosis: A review.

Xu Z, Zhang R, Chen H, Zhang L, Yan X, Qin Z Food Chem X. 2024; 23:101530.

PMID: 38933991 PMC: 11200288. DOI: 10.1016/j.fochx.2024.101530.


Thermodynamic and molecular dynamic insights into how fusion influences peptide-tag recognition of an antibody.

Miyanabe K, Yamashita T, Tsumoto K Sci Rep. 2024; 14(1):8685.

PMID: 38622354 PMC: 11018781. DOI: 10.1038/s41598-024-59355-2.


Abatement of the binding of human hexokinase II enzyme monomers by in-silico method with the design of inhibitory peptides.

Karamifard F, Mazaheri M, Dadbinpour A In Silico Pharmacol. 2024; 12(1):30.

PMID: 38617709 PMC: 11009198. DOI: 10.1007/s40203-024-00201-8.


References
1.
Pirtskhalava M, Amstrong A, Grigolava M, Chubinidze M, Alimbarashvili E, Vishnepolsky B . DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res. 2020; 49(D1):D288-D297. PMC: 7778994. DOI: 10.1093/nar/gkaa991. View

2.
Hung L, Ngan S, Liu T, Samudrala R . PROTINFO: new algorithms for enhanced protein structure predictions. Nucleic Acids Res. 2005; 33(Web Server issue):W77-80. PMC: 1160164. DOI: 10.1093/nar/gki403. View

3.
Wang Z, Wang G . APD: the Antimicrobial Peptide Database. Nucleic Acids Res. 2003; 32(Database issue):D590-2. PMC: 308759. DOI: 10.1093/nar/gkh025. View

4.
Morrison K, Weiss G . Combinatorial alanine-scanning. Curr Opin Chem Biol. 2001; 5(3):302-7. DOI: 10.1016/s1367-5931(00)00206-4. View

5.
Halabi N, Rivoire O, Leibler S, Ranganathan R . Protein sectors: evolutionary units of three-dimensional structure. Cell. 2009; 138(4):774-86. PMC: 3210731. DOI: 10.1016/j.cell.2009.07.038. View